Dialysis Access and Quality

Improving Dialysis Care

Under original Medicare, dialysis is paid for in a bundled payment to dialysis facilities meant to cover the costs of delivering treatment, home dialysis equipment, and certain, dialysis related medications and laboratory tests. NKF regularly monitors payment to dialysis facilities to ensure patients have access to high quality care. In addition, we frequently make comments on how Medicare can improve quality through evidence based quality measures, incentive programs, and patient engagement.

Latest Dialysis Access Updates

10/16/18 — The National Kidney Foundation submitted comments to the North Carolina Department of Health and Human Services regarding proposed changes to Medicaid and Health Choice Clinical Coverage Policy No: 1A-34, End Stage Renal Disease (ESRD) Services. Read the comments here (pdf).

11/09/2018— The National Kidney Foundation submitted comments to the Centers for Medicare and Medicaid Services regarding the 2019 ESRD Prospective Payment System and Quality Incentive Program Final Rule, and 2019 Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B.
PFS and QPP Final Rule Summary (pdf)
ESRD PPS QIP Final Rule Summary (pdf)

9/13/18 — The National Kidney Foundation submitted comments to Governor Brown (CA) regarding concerns that SB 1156 may cause kidney patient to lose access to charitable premium assistance and choice in insurance coverage. Read the full comments (pdf).

9/10/18 — The National Kidney Foundation submitted comments to CMS on the CY2019 Physician Fee Schedule proposed rule. Read the full comments (pdf).

9/5/18— The National Kidney Foundation submitted comments to the Centers for Medicare and Medicaid Services regarding the 2019 proposed End-Stage Renal Disease Prospective Payment System (ESRD PPS) and Quality Incentive Program (QIP) Proposed Rule.
Read comments on ESRD PPS Payments (pdf)
Read comments on ESRD PPS and QIP (pdf)
Read comments on ESRD PPS QIP and Home Dialysis and Transplant (pdf)

7/19/18— The National Kidney Foundation submitted comments about proposed guidance for vascular procedures in Pennsylvania. Read the full comments(pdf).

5/11/18 — The National Kidney Foundation submitted comments about SB 1156, which would single out and limit people with end-stage renal disease's (ESRD) ability to receive charitable assistance to help pay for health insurance. Read the full comments (pdf).

3/2/18 — The National Kidney Foundation submitted comments to CMS on several proposed changes to how the agency calculates payments to Medicare Advantage and Part D plans. These changes will impact CKD and ESRD patients access to these plans and the benefits they receive. Read the full comments (pdf).

11/21/17 — The National Kidney Foundation submitted comments to CMS about the coordinated draft Local Coverage Determinations (LCD) for Frequency of Hemodialysis. Read the final comments (pdf).

9/22/17 — The National Kidney Foundation submitted comments to CMS on the proposed changes to the end-stage renal disease (ESRD) prospective payment system (PPS), including policies that will govern coverage and payment for renal dialysis services delivered to individuals with acute kidney injury (AKI), and the quality incentive program (QIP) for payment years 2019-2021. Read the final comments (pdf).

9/15/17 — The National Kidney Foundation is pleased to endorse H.R. 2644, introduced by Representatives Tom Marino (R-PA), John Lewis (D-GA) and Peter Roskam (R-IL). The legislation would benefit chronic kidney disease (CKD) patients by expanding access to health insurance options, creating greater opportunities for research and innovation, increasing access to various treatment options, and improving patient care and quality outcomes. Read the full statement (PDF).

7/26/17 — NKF submitted comments to the leadership of the House Energy and Commerce Committee commending them for holding a committee hearing to examining Medicare Advantage Special Needs Plans (SNPs) and expressing NKF's support for Chronic Condition Special Needs Plans (C-SNPs) and Dual-Eligible SNPs. Read the final comments (pdf).

4/25/17 — NKF submitted comments to the California Senate Judiciary Committee on SB 349, which legislates the staffing ratios and shift transition times of Registered Nurses per patient. Read the final comments (pdf).

1/12/17 — NKF submitted comments to CMS regarding the Interim Final Rule Medicare Program; Conditions for Coverage for End-Stage Renal Disease (ESRD) Facilities--Third Party Payment. The interim rule would impact the education regarding, and ability of patients to receive, third-party premium assistance for health care insurance coverage. Read the final comments (pdf).

11/2/16 — NKF released this statement of support for H.R. 6265, the Medigap Consumer Protection Act. The Medigap Consumer Protection Act will accomplish several important goals, including helping end discriminatory treatment of Medicare beneficiaries by extending guaranteed issue rights to the entire Medicare-eligible population. Read the statement (pdf).

9/26/16 — NKF submitted final comments to the Center for Medicare & Medicaid regarding its "Request for Information: Inappropriate Steering of Individuals Eligible for or Receiving Medicare and Medicaid Benefits to Individual Market Plans." Read the final comments (pdf).

8/29/16 — NKF submitted comments to the Centers for Medicare & Medicaid Services (CMS) on proposed changes to methodology of the Dialysis Five Star Program. Read the final comments (pdf).

3/14/16 — NKF submitted comments to the Centers for Medicare & Medicaid Services (CMS) on proposed changes to methodology of the Dialysis Five Star Program. Read the final comments (pdf).

2/8/16 — NKF submitted comments to the University of Michigan Epidemiology and Cost Center on the CMS Vascular Access and Transplant waitlist measures proposed for development. Read the final comments (pdf).

2/1/16 — NKF submitted comments to the Idaho State Office of the Insurance Commission regarding discriminatory plan designs by several insurers for end-stage renal disease (ESRD) patients. Read the full comments (pdf).

1/26/16 — NKF submitted comments to the Washington State Office of the Insurance Commission regarding discriminatory plan designs by several insurers for end-stage renal disease (ESRD) patients. Read the full comments (pdf).

2015 (click to expand)